Transarterial Chemoembolization With Cisplatin as Second-Line Treatment for Hepatocellular Carcinoma Unresponsive to Chemoembolization With Epirubicin-Lipiodol Emulsion

Noboru Maeda; Keigo Osuga; Hiroki Higashihara; Kaname Tomoda; Koji Mikami; Tetsuro Nakazawa; Hironobu Nakamura; Noriyuki Tomiyama

首页> 外文期刊>CardioVascular and Interventional Radiology >Transarterial Chemoembolization With Cisplatin as Second-Line Treatment for Hepatocellular Carcinoma Unresponsive to Chemoembolization With Epirubicin-Lipiodol Emulsion

【24h】

Transarterial Chemoembolization With Cisplatin as Second-Line Treatment for Hepatocellular Carcinoma Unresponsive to Chemoembolization With Epirubicin-Lipiodol Emulsion

机译：顺铂经动脉化疗栓塞治疗肝细胞癌对表柔比星-脂质体乳剂对化疗栓塞无反应的二线治疗

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose The purpose of this retrospective study was to investigate the efficacy of transarterial chemoembolization (TACE) using cisplatin as a second-line treatment for advanced hepatocellular carcinoma (HCC) unresponsive to TACE using epirubicin–Lipiodol emulsion at our institution.

机译：目的这项回顾性研究的目的是研究在我们机构中使用顺铂作为经二线治疗的晚期肝细胞癌（HCC）对TACE无反应的晚期肝细胞癌（HCC）的二线治疗的疗效。

著录项

来源
《CardioVascular and Interventional Radiology》 |2012年第1期|p.82-89|共8页
作者
Noboru Maeda; Keigo Osuga; Hiroki Higashihara; Kaname Tomoda; Koji Mikami; Tetsuro Nakazawa; Hironobu Nakamura; Noriyuki Tomiyama;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-lipiodol emulsion [J] . MaedaN., OsugaK., HigashiharaH., Cardiovascular and Interventional Radiology: A Journal of Imaging in Diagnosis and Treatment . 2012,第1期

机译：顺铂经动脉化学栓塞治疗肝细胞癌对表柔比星-碘油乳剂对化学栓塞无反应的二线治疗
2. A retrospective comparative study of epirubicin-lipiodol emulsion and cisplatin-lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma. [J] . Yodono H, Matsuo K, Shinohara A Anti-cancer drugs . 2011,第3期

机译：回顾性比较研究表柔比星-碘油乳剂和顺铂-碘油混悬液与经导管动脉化学栓塞治疗肝细胞癌的关系。
3. Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score-based weighting [J] . Kondo Masaaki, Morimoto Manabu, Ishii Tomohiro, Journal of digestive diseases . 2015,第3期

机译：顺铂和索拉非尼对经动脉化疗栓塞无反应的肝癌患者的肝动脉灌注化疗：基于倾向评分的权重
4. Improved quantitative contrast-enhanced ultrasound imaging of hepatocellular carcinoma response to transarterial chemoembolization [C] . Ipek Oezdemir, Collette Shaw, John R. Eisenbrey, IEEE International Symposium on Biomedical Imaging . 2019

机译：改进的肝细胞癌对经动脉化疗栓塞反应的定量对比增强超声成像
5. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model. [D] . Chen, Zheng. 2016

机译：倍半萜类药物可作为肝细胞癌（HCC）的潜在治疗方法：在大鼠HCC肿瘤模型中，通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
6. Comparison of treatment efficacy and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres® microspheres and conventional transarterial chemoembolization as first-line treatment in hepatocellular carcinoma patients [O] . Yilong Ma, Chang Zhao, Hui Zhao, 2019

机译：比较CalliSpheres®微球与常规经动脉化学栓塞作为肝细胞癌患者一线治疗药物洗脱珠子经动脉栓塞的疗效和安全性
7. Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres® Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis [O] . Bin Liang, Joyman Makamure, Shenglei Shu, 2021

机译：Callisberes®Microshizesrelisterpheres®微球的治疗响应，存活和安全性与肝细胞癌中的常规常规化疗栓塞：Meta分析

Transarterial Chemoembolization With Cisplatin as Second-Line Treatment for Hepatocellular Carcinoma Unresponsive to Chemoembolization With Epirubicin-Lipiodol Emulsion

摘要

著录项

相似文献

相关主题

期刊订阅